Abstract
The IgG2b monoclonal antibody M10/76, which is specific for the Hooded rat fibrosarcoma MC24, was obtained by fusion of the rat myeloma Y3 Ag 1.2.3 with spleen cells from an MC24 tumour-bearing rat. This antibody has been found to inhibit lung colonization when MC24 cells were injected i.v. into Hooded rats, and when passively transferred into athymic MC24 tumour bearers, it prevented or considerably reduced the incidence of spontaneous lung metastases in more than half the treated animals.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Currie G. A., Gage J. O. Influence of tumour growth on the evolution of cytotoxic lymphoid cells in rats bearing a spontaneously metastasizing syngeneic fibrosarcoma. Br J Cancer. 1973 Aug;28(2):136–146. doi: 10.1038/bjc.1973.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eccles S. A., Heckford S. E., Alexander P. Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours. Br J Cancer. 1980 Aug;42(2):252–259. doi: 10.1038/bjc.1980.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eccles S. A., Styles J. M., Hobbs S. M., Dean C. J. Metastasis in the nude rat associated with lack of immune response. Br J Cancer. 1979 Nov;40(5):802–805. doi: 10.1038/bjc.1979.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Galfrè G., Milstein C., Wright B. Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature. 1979 Jan 11;277(5692):131–133. doi: 10.1038/277131a0. [DOI] [PubMed] [Google Scholar]
- Herlyn D., Koprowski H. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4761–4765. doi: 10.1073/pnas.79.15.4761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirch M. E., Hammerling U. Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells. J Immunol. 1981 Aug;127(2):805–810. [PubMed] [Google Scholar]
- Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Mar 4;306(9):517–522. doi: 10.1056/NEJM198203043060906. [DOI] [PubMed] [Google Scholar]
- Nadler L. M., Stashenko P., Hardy R., Kaplan W. D., Button L. N., Kufe D. W., Antman K. H., Schlossman S. F. Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res. 1980 Sep;40(9):3147–3154. [PubMed] [Google Scholar]
- North S. M., Styles J. M., Hobbs S. M., Dean C. J. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production. Immunology. 1982 Nov;47(3):397–405. [PMC free article] [PubMed] [Google Scholar]
- Proctor J. W., Auclair B. G., Rudenstam C. M. The distribution and fate of blood-borne 125IUdR-labelled tumour cells in immune syngeneic rats. Int J Cancer. 1976 Aug 15;18(2):255–262. doi: 10.1002/ijc.2910180217. [DOI] [PubMed] [Google Scholar]
- Ritz J., Pesando J. M., Notis-McConarty J., Clavell L. A., Sallan S. E., Schlossman S. F. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia. Cancer Res. 1981 Nov;41(11 Pt 2):4771–4775. [PubMed] [Google Scholar]
- Weiss L., Glaves D., Waite D. A. The influence of host immunity on the arrest of circulating cancer cells, and its modification by neuraminidase. Int J Cancer. 1974 Jun 15;13(6):850–862. doi: 10.1002/ijc.2910130612. [DOI] [PubMed] [Google Scholar]
- Young W. W., Jr, Hakomori S. I. Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo. Science. 1981 Jan 30;211(4481):487–489. doi: 10.1126/science.7455688. [DOI] [PubMed] [Google Scholar]